Diseases

The Sabin Vaccine Institute works to extend the benefits of immunization to all people by enabling vaccine access and uptake. Sabin brings together national government officials, policy makers, immunization specialists, researchers and advocates to supply decision makers with the data and expertise they need to make evidence-based decisions on vaccines. Our work includes a number of diseases, including:

Supporting Evidence-Based Decisions

Vaccine introduction, policy and financing are complex issues, and countries must achieve ambitious immunization targets with limited available resources. To make informed decisions for the health of their people, decision makers need accurate, up-to-date information to identify vulnerable populations, assess burden of disease, evaluate vaccine efficacy and cost-effectiveness, and measure the efficiency of immunization programs.

In February, Sabin convened 70 immunization managers from 30 countries to discuss an issue of increasing concern to public health experts around the world: vaccine acceptance and demand.

Special Projects

 
Sabin works with partners around the world, including the World Health Organization (WHO), the Pan American Health Organization (PAHO), Fundação Oswaldo Cruz (FIOCRUZ) and the Bill & Melinda Gates Foundation, to convene symposiums that have brought together more than 2,400 of the world’s global health stakeholders to work on advancing vaccination as a cost-effective weapon in public health.
 
Sabin is dedicated to reducing the burden and impact of infectious diseases through the use of new and underutilized vaccines.
What do neglected tropical diseases (NTDs) have to do with women’s health? A recent review entitled, “Effective Health Interventions for Adolescents That Could Be Integrated with Human Papillomavirus Vaccination Programs”, has just been published looking at how combining multiple health interventions with human papillomavirus (HPV) vaccinations increases the effectiveness of HPV delivery.

Pages

Subscribe to RSS - Human Papillomavirus (HPV)